{
  "@context": "aku-v2",
  "@type": "genetics",
  "@id": "vasc:genet:adpkd-aneurysms",
  "metadata": {
    "version": "2.0.0",
    "created": "2026-01-07T03:18:00.000Z",
    "updated": "2026-01-07T03:18:00.000Z",
    "contributors": ["knowledge-graph-agent"],
    "confidence": 0.92,
    "status": "pending-quality-check"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/genetic-disorders",
    "type": "genetic-syndrome",
    "difficulty": "advanced",
    "importance": "high"
  },
  "content": {
    "title": "Intracranial Aneurysms in ADPKD",
    "description": "Association between autosomal dominant polycystic kidney disease and intracranial aneurysms",
    "key_concepts": [
      {
        "concept": "Prevalence",
        "details": "Intracranial aneurysms occur in 6-11% of ADPKD patients vs 2-3% general population"
      },
      {
        "concept": "Screening Indications",
        "details": "Screen those with family history of subarachnoid hemorrhage or intracranial aneurysm"
      },
      {
        "concept": "Screening Modality",
        "details": "MRA preferred; repeat every 5-10 years if negative with positive family history"
      },
      {
        "concept": "Management",
        "details": "Treatment thresholds similar to general population; consider lower threshold if family history"
      }
    ],
    "clinical_significance": "Leading cause of death in ADPKD other than renal failure"
  },
  "provenance": {
    "primary_sources": ["Perrone RD et al. J Am Soc Nephrol 2015"]
  }
}
